Showing results (61-70 of 83) with videos related to
Sort By:
Pageof 9
Journal of Diabetes Science and Technology|November 4, 2022
Continuous Glucose Deviation Interval and Variability Analysis (CG-DIVA): A Novel Approach for the Statistical Accuracy Assessment of Continuous Glucose Monitoring SystemsManuel Eichenlaub, Peter Stephan, Delia Waldenmaier, et al.Diabetes, Obesity & Metabolism|June 20, 2019
Improved treatment satisfaction in patients with type 2 diabetes treated with once-weekly semaglutide in the SUSTAIN trialsJohan Jendle, Andreas L Birkenfeld, William H Polonsky, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 2, 2024
The Determination of Diabetes Utilities, Costs, and Effects Model: A Cost-Utility Tool Using Patient-Level Microsimulation to Evaluate Sensor-Based Glucose Monitoring Systems in Type 1 and Type 2 Diabetes: Comparative ValidationKirk Szafranski, Gerard De Pouvourville, Dan Greenberg, et al.Diabetic Medicine : a Journal of the British Diabetic Association|May 22, 2026
Cost-effectiveness of control-IQ automated insulin delivery in adults with type 1 diabetes in SwedenJohan Jendle, Nuno Picado, Carolina Bulhosa, et al.Diabetes, Obesity & Metabolism|February 5, 2025
MiniMed 780G system performance in older users with type 1 diabetes: Real-world evidence and the case for stricter glycaemic targetsVittorino Smaniotto, Simon Heller, David O'Neal, et al.BMJ Open Diabetes Research & Care|April 1, 2021
Effects of nutrition education using a food-based approach, carbohydrate counting or routine care in type 1 diabetes: 12 months prospective randomized trialSofia Sterner Isaksson, Margareta Bensow Bacos, Björn Eliasson, et al.BMJ (Clinical Research Ed.)|June 24, 2015
Insulin pump therapy, multiple daily injections, and cardiovascular mortality in 18,168 people with type 1 diabetes: observational studyIsabelle Steineck, Jan Cederholm, Björn Eliasson, et al.Journal of Medical Economics|August 5, 2020
Real-world cost-effectiveness of insulin degludec in type 1 and type 2 diabetes mellitus from a Swedish 1-year and long-term perspectiveJohan Jendle, Åsa Ericsson, Bertil Ekman, et al.Diabetologia|December 2, 2023
A narrative commentary about interoperability in medical devices and data used in diabetes therapy from an academic EU/UK/US perspectiveJohan Jendle, Peter Adolfsson, Pratik Choudhary, et al.Evidence-Based Mental Health|November 17, 2022
Risk prediction model for cardiovascular diseases in adults initiating pharmacological treatment for attention-deficit/hyperactivity disorderMaja Dobrosavljevic, Seena Fazel, Ebba Du Rietz, et al.Pageof 9